StephN
06-08-2006, 12:43 PM
Like me some of the others out there have had trouble qualifying for the HER2 vaccine trials (and I am right here in Seattle!). Tried for the peptide trial and had the wrong HLA number. Tried for the DNA based trial and have a positive ANA (inflammation) reponse which disqualified me.
NOW Patty F at the U of W sends me word of yet another vaccine trial. This is not for HER2 specific cancers but has another target so is open to others NOT Her2 positive.
The TROVAX vaccine will begin a phase II study the end of summer. It is not specifically a HER2 target, but works against 5T4, something common to tumors of various origins.
Only thing is :
"This phase II trial is studying how well vaccine therapy works in treating patients with stage IIIB or stage IV breast cancer in remission."
Remission is required for this Trovax study and at this time I qualify. The trial criteria says that bone mets is the only qualifier, but Patty says that has been changed and the patient can have had mets anywhere and qualify. They are updating the wording.
If interested check this link:
http://www.clinicaltrials.gov/ct/show/NCT00227474?order=1 (http://www.clinicaltrials.gov/ct/show/NCT00227474?order=1)
NOW Patty F at the U of W sends me word of yet another vaccine trial. This is not for HER2 specific cancers but has another target so is open to others NOT Her2 positive.
The TROVAX vaccine will begin a phase II study the end of summer. It is not specifically a HER2 target, but works against 5T4, something common to tumors of various origins.
Only thing is :
"This phase II trial is studying how well vaccine therapy works in treating patients with stage IIIB or stage IV breast cancer in remission."
Remission is required for this Trovax study and at this time I qualify. The trial criteria says that bone mets is the only qualifier, but Patty says that has been changed and the patient can have had mets anywhere and qualify. They are updating the wording.
If interested check this link:
http://www.clinicaltrials.gov/ct/show/NCT00227474?order=1 (http://www.clinicaltrials.gov/ct/show/NCT00227474?order=1)